Enhanced Biofeedback for Musculoskeletal Pain
Testing the Efficacy of Enhanced Biofeedback on Chronic Musculoskeletal Pain
1 other identifier
interventional
6
1 country
1
Brief Summary
The purpose of this study is to assess whether a novel, enhanced form of biofeedback can help individuals regulate their chronic musculoskeletal pain more effectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
September 26, 2016
CompletedFirst Posted
Study publicly available on registry
September 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedAugust 21, 2018
August 1, 2018
1.9 years
September 26, 2016
August 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in clinical pain
Self-report ratings of pain intensity, rated using 0-10 Likert-type scales, (i.e., 0 = no pain; 10 = most intense pain).
Assessed daily via electronic diaries starting 1 week prior to session 1 and ending 1 week after session 10 (up to 11 weeks)
Changes in psychosocial outcomes
Self-report ratings of pain interference, mood, sleep quality, and coping. These items are rated using 0-10 Likert-type scales, (e.g., 0 = no change; 10 = extreme change) with higher values indicating an increase in the variable assessed on a particular item (e.g., interference with daily activities).
Assessed daily via electronic diaries starting 1 week prior to session 1 and ending 1 week after session 10 (up to 11 weeks)
Secondary Outcomes (1)
Changes in reactions to painful stimuli
Assessed immediately before the first treatment session (Time 1) and immediately after (Time 2) the last treatment session (approximately 10 weeks from Time 1).
Study Arms (2)
BT-CPR
EXPERIMENTALParticipants will receive training in relaxation and biofeedback to develop skills in relaxation/arousal reduction, and pain reduction. Then they will practice relaxing and reducing their arousal as they view graphical arousal feedback. Electric stimulations will be delivered throughout the biofeedback training to provide pain relief when relaxation is achieved.
Biofeedback-Only
ACTIVE COMPARATORParticipants will receive training in relaxation and biofeedback to develop skills in relaxation/arousal reduction, and pain reduction. Then they will practice relaxing and reducing their arousal as they view graphical arousal feedback.
Interventions
Participants will receive biofeedback training (which will include electric stimulations) to reduce arousal and pain
Participants will receive biofeedback training to reduce arousal and pain
Eligibility Criteria
You may qualify if:
- Adults (18 years or older) with a verified diagnosis of chronic musculoskeletal pain and currently experiencing pain
You may not qualify if:
- under 18 years of age (given the nature of the treatment study)
- if female, currently pregnant
- persistent feelings of numbness in hands and feet
- difficulty being able to feel or sense things
- lack of access to a computer or smartphone (to complete electronic pain diaries)
- injuries that prevent sensor application
- use of narcotic pain medications with 48 hours of treatment sessions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Tulsa
Tulsa, Oklahoma, 74104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jamie L Rhudy, PhD
The University of Tulsa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 26, 2016
First Posted
September 30, 2016
Study Start
September 1, 2016
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
August 21, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share